Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Metastatic Breast Cancer”

664 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 664 results

Testing effectiveness (Phase 2)Study completedNCT03659136
What this trial is testing

The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 103
Testing effectiveness (Phase 2)Study completedNCT02650193
What this trial is testing

The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Who this might be right for
Non-metastatic Breast Cancer
Pfizer 25
Testing effectiveness (Phase 2)Study completedNCT00301899
What this trial is testing

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab

Who this might be right for
Breast Cancer
National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872
What this trial is testing

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more
Cybrexa Therapeutics 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339176
What this trial is testing

Intratumoral N17350 in Advanced Solid Tumors

Who this might be right for
Neoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more
Onchilles Pharma Inc 275
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT01134250
What this trial is testing

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

Who this might be right for
Solid TumorBreast CancerMetastatic Melanoma+1 more
Philogen S.p.A. 48
Testing effectiveness (Phase 2)Study completedNCT01387373
What this trial is testing

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Who this might be right for
Metastatic Breast CancerLiver Metastases
Dorte Nielsen 14
Early research (Phase 1)Looking for participantsNCT06253520
What this trial is testing

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Who this might be right for
Metastatic Solid CancersColorectal CancerBreast Cancer+4 more
National Cancer Institute (NCI) 210
Early research (Phase 1)Study completedNCT00039052
What this trial is testing

Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer

Who this might be right for
Breast CancerKidney CancerLung Cancer
Neurocrine Biosciences
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Not applicableStudy completedNCT00900835
What this trial is testing

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

Who this might be right for
Breast CancerColorectal CancerFatigue+3 more
City of Hope Medical Center 470
Testing effectiveness (Phase 2)Ended earlyNCT02202746
What this trial is testing

Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast CancerMBC+5 more
Clovis Oncology, Inc. 178
Not applicableStudy completedNCT06686602
What this trial is testing

A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer

Who this might be right for
Advanced/Metastatic NSCLCAdvanced/Metastatic HER2-negative Breast Cancer
Daiichi Sankyo 13,759
Not applicableStudy completedNCT01459653
What this trial is testing

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Who this might be right for
Febrile NeutropeniaCancerBreast Cancer+6 more
Sandoz 1,496
Not applicableStudy completedNCT00003329
What this trial is testing

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
ITM Oncologics GmbH 270
Not applicableStudy completedNCT05769751
What this trial is testing

Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Daiichi Sankyo 865
Early research (Phase 1)Ended earlyNCT01929941
What this trial is testing

An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies

Who this might be right for
Solid TumorHodgkin's LymphomaNHL (Non-Hodgkin Lymphoma)+5 more
Incyte Corporation 5
Testing effectiveness (Phase 2)Study completedNCT00078845
What this trial is testing

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Who this might be right for
Breast CancerLung CancerNeurotoxicity+3 more
M.D. Anderson Cancer Center 24
Load More Results